Drug
Avacincaptad Pegol
Avacincaptad Pegol: highest development phase Post-Market, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| avacincaptad pegol NCT06970665 | Post-Market | Geographic Atrophy |
Latest
No recent events.
Follow Avacincaptad Pegol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.